CIK 0001730463 · Non-accelerated filer<br>Smaller reporting company
Autolus Therapeutics plc
Sign in to watch- Ticker
- AUTL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 20 3829 6230
- Business address
- THE MEDIAWORKS, 191 WOOD LANE, LONDON, United Kingdom, W12 7FP
- Former names
- Autolus Therapeutics Ltd
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B3 Offering Prospectus
- 8-K Event Material agreement
- 424B3 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B3 Offering Prospectus
- 8-K Event Executive or director change · Regulation FD disclosure
- S-8 Other Securities Offered to Employees in Benefit Plans
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B3 Offering Prospectus
Page 4 of 17 · 340 filings